Search

everythinglearnresearchcommunity

for

Search:↓

Cosmeceuticals may benefit skin health but need more research for efficacy and safety confirmation.

Robotic hair transplantation with AI offers more reliable, precise, and efficient hair restoration.

Ancient DNA blocks are still present in human genomes, possibly due to advantages they provide.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Flow cytometry was effective in diagnosing metastatic breast cancer in a bone marrow sample.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Different types of long-lasting stem cells are responsible for the growth and upkeep of the mammary gland.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

Adding stem cells to fat grafts for facial rejuvenation might improve outcomes, but more research is needed to confirm safety and effectiveness.

The document concludes that accurately identifying leukemia types is crucial, and the risks of cancer from finasteride need careful evaluation against its benefits.

Citrus lemon and ginger essential oils show promise for cancer treatment and antioxidant benefits.

An elderly woman's upper lip lump, thought to be a mucocele, was actually a rare type of lymphoma usually found on legs, treated successfully with chemotherapy and radiation.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

The meeting highlighted the genetic basis of female pattern hair loss and various skin health insights.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Tamoxifen caused hair loss in a 52-year-old woman.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

PLD is an effective and safer alternative for treating breast cancer.

Some breast cancer chemotherapy can cause permanent hair loss.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

No definitive link between finasteride and male breast cancer, but further research is needed.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.